1-9 of 9
Valérie Ugo, MD, PhD
Close
Sort by
Journal Articles

Prediction of One-Year Molecular Response to Imatinib at Diagnosis of Chronic Myeloid Leukemia By Scoring Gene Expression Levels of Antioxidant Enzymes

Frederic Picou, PhD, Jean-Claude Chomel, PharmD PhD, Marie Christine Bene, PharmD, Marc G. Berger, MD PhD, Thierry Fest, Valerie Ugo, MD PhD, Eric Lippert, MD PhD, Marion Socco-Luca, Martine Delain, MD, Marie-Helene Estienne, PharmD, Olivier Herault, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3024.
https://doi.org/10.1182/blood-2018-99-118297
Published: 2018
Journal Articles

Long Term Outcome of Patients with MPN-Associated Myelofibrosis Treated with Peg-Interferon-α2a, a French Intergroup of Myeloproliferative Neoplasms (FIM) Study

Jean-Christophe Ianotto, MD, Aurélie Chauveau, MD, Francoise Boyer-Perrard, MD, Emmanuel Gyan, MDPhD, Kamel Laribi, Pascale Cony-Makhoul, MD PhD, Jean-Loup Demory, MD PhD, Benoit De Renzis, MD, Christine Dosquet, MD, Jerome Rey, MD, Lydia Roy, MD, Brigitte Dupriez, MD PhD, Laurent Knoops, MD PhD, Laurence Legros, MD PhD, Mohamed Malou, MD PhD, Pascal Hutin, MD, Dana Ranta, MD, Omar Benbrahim, MD, Valerie Ugo, MD PhD, Eric Lippert, MD PhD, Jean-Jacques Kiladjian, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 323.
https://doi.org/10.1182/blood.V130.Suppl_1.323.323
Published: 2017
Journal Articles

Efficacy and Safety of Erythropoietic-Stimulating Agents with Ruxolitinib in Myelofibrosis Patients : A Retrospective Analysis on 45 Patients. on Behalf of the French Intergroup of Myeloproliferative Disorders (FIM)

Sandra Malak, MD, Pascale Cony-Makhoul, MD, Jean-Christophe Ianotto, MD, Dana Ranta, MD, Philippe Rodon, MD, Fabienne Vacheret, MD, Barraco Fiorenza, MD, Francoise Boyer, MD, Katell Le Du, MD, Loic Garcon, MD PhD, Francois Lefrere, MD, Mathieu Wemeau, MD, Valerie Ugo, MD PhD, Jean-Jacques Kiladjian, MD PhD, Lydia Roy, MD
Journal: Blood
Blood (2016) 128 (22): 3123.
https://doi.org/10.1182/blood.V128.22.3123.3123
Published: 2016
Journal Articles

Myelofibrosis in Real Life: Findings from the French Intergroup of Myeloproliferative Neoplasms (FIM) Registry

Brigitte Dupriez, MD, Sylvie Chevret, MD PhD, Jean-Christophe Ianotto, MD, Francoise Boyer, MD, Pascale Cony-Makhoul, MD, Gabriel Etienne, MD PhD, Mathieu Wemeau, MD, Jérome Rey, Laurent Knoops, MD PhD, Jean-Loup Demory, MD, Eric Lippert, PhD, Francois Girodon, MD PhD, Laurence Legros, MDPhD, Anne Vekhoff, MD, Stephane Courby, MD, Fabienne Vacheret, MD, Nathalie Cambier, MD, Stephane Giraudier, MD PhD, Suzanne Tavitian, MD, Kamel Laribi, Sandra Malak, Dana Ranta, MD, Fiorenza Barraco, MD, Isabelle Plantier, MD, Sophie Dupire, Marc Simon, MD, Selim Corm, MD, Ahmad AL Jijakli, MD, Philippe Rodon, MD, Lise Willems, MD PhD, Bohrane Slama, MD, Ronan Le Calloch, MD, Pierre Morel, MD, Valerie Ugo, MD PhD, Jean-Jacques Kiladjian, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3128.
https://doi.org/10.1182/blood.V128.22.3128.3128
Published: 2016
Journal Articles

Sequential Analysis By Next Generation Sequencing of 18 Genes in Polycythemia Vera and Essential Thrombocythemia Reveals a Association Between Mutational Status and Clinical Outcome after 3-Year Follow-up

Damien Luque Paz, MD, Aurelie Chauveau, MD, Caroline Buors, MD, Jean-Christophe Ianotto, MD, Francoise Boyer, MD, Laura Samaison, MD, Claude Ferec, MD PhD, Cedric Le Marechal, MD PhD, Paul Gueguen, MD, Valerie Ugo, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2808.
https://doi.org/10.1182/blood.V126.23.2808.2808
Published: 2015
Journal Articles

Incidence and Localization of Vascular Events in a Well Characterized Cohort of 477 Patients with Myeloproliferative Neoplasms

Aurélie Chauveau, MD, Damien Luque Paz, MDstudent, Ronan Le Calloch, MDStudent, Caroline Buors, MD, Lydie Lecucq, Dominique Mottier, MD PhD, Valérie Ugo, MD PhD, Jean-Christophe Ianotto, MD
Journal: Blood
Blood (2014) 124 (21): 1854.
https://doi.org/10.1182/blood.V124.21.1854.1854
Published: 2014
Journal Articles

Differential Association of Calreticulin Type 1 and Type 2 Mutations with Myelofibrosis and Essential Thrombocytemia: Relevance for Disease Evolution

Xenia Cabagnols, undegraduate, Jean-Philippe Defour, BPharm,, Valérie Ugo, MD PhD, Jean Christophe Ianotto, Pascal Mossuz, Julie Mondet, Francois Girodon, MD PhD, Alexandre Ji-Hye, MD, Olivier Mansier, MD, Jean François Viallard, MD, Eric Lippert, Anne Murati, MD, MJ Mozziconacci, Ollivier Legrand, MD PhD, Pascale Saussoy, Marie-Christianne Vekemans, MD, Laurent Knoops, Florence Pasquier, Vincent Ribrag, Eric Solary, Isabelle Plo, Stefan N. Constantinescu, MD PhD, Nicole Casadevall, MD, William Vainchenker, MD, PhD, Christophe Marzac, MD, Olivier Bluteau, PhD
Journal: Blood
Blood (2014) 124 (21): 1823.
https://doi.org/10.1182/blood.V124.21.1823.1823
Published: 2014
Journal Articles

Impact of the Molecular Profile of Malignant Clones on the Response to Interferon Alpha (IFNa) Therapy in JAK2V617F-Negative Essential Thrombocythemia (ET)

Emmanuelle Verger, PhD, Bruno Cassinat, PharmD, PhD, Christine Dosquet, MD PhD, Marie-Helene Schlageter, Valérie Ugo, MD PhD, Jean-Christophe Ianotto, MD, Mohamed A. Yassin, MBBS ,MSc,CABM,FACP, Nader Dewik, PhD, Serge Carillo, PhD, Christine Chomienne, MD PhD, Jean-Jacques Kiladjian, MD PhD
Journal: Blood
Blood (2014) 124 (21): 407.
https://doi.org/10.1182/blood.V124.21.407.407
Published: 2014
Journal Articles

Sequential Measurement Of JAK2 V617F Allele Burden In Polycythemia Vera and Essential Thrombocythemia Reveals Different Evolution Profiles: First Results Of Jaksuivi, a Multicentre Study By The French Intergroup Of Myeloproliferative Neoplasms (FIM)

Caroline Buors, Françoise Boyer, Aline Tanguy-Schmidt, Aurélie Chauveau, Lydia Roy, MD, Jean-Claude Chomel, PharmD, PhD, Thierry Lamy, MD, PhD, Olivier Fardel, Olivier Herault, MD, PhD, Laura Samaison, Valérie Ugo, MD, PhD, Jean-Christophe Ianotto, MD
Journal: Blood
Blood (2013) 122 (21): 1593.
https://doi.org/10.1182/blood.V122.21.1593.1593
Published: 2013